EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Measurement of Disease Burden in Oropharyngeal Cancer

Lucas Penny, Eric Yang Stutheit-Zhao, Birgitta E Michels, Fabian Rosing, Zhen Zhao, Yangqiao Zheng, Jinfeng Zou, Shao Hui Huang, Johnny Carlton, Andrew McPartlin, John R de Almeida iD, David Goldstein und 12 weitere

International Journal of Cancer · 2026

DOI: 10.1002/ijc.70619 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Lucas Penny und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biophysics, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Oropharyngeal Neoplasms, Papillomavirus Infections, DNA, Viral, Circulating Tumor DNA. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incidence of human papillomavirus‐positive (HPV+) oropharyngeal cancer (OPC) has increased rapidly, and HPV early antigen serology has been proposed as a scalable and cost‐effective early detection test. HPV seropositivity can precede clinical presentation of OPC by several years, so additional surveillance procedures may be necessary to optimize early cancer detection. The potential for HPV circulating tumor DNA (ctDNA) to confirm a diagnosis of OPC in seropositive individuals is poorly understood. Here, we assess the relationship between HPV serology and HPV ctDNA with disease burden in a large cohort of HPV+ OPC. We analyzed baseline blood samples from 262 patients using a multiplex serology assay and an HPV‐targeted deep sequencing assay (HPV‐seq), and HPV‐seq results were validated by an orthogonal droplet digital PCR assay. Both assays identified HPV16 as the most prevalent genotype (84%), with serology results indicating a total of 4 HPV genotypes and HPV ctDNA results indicating a total of 6 HPV genotypes. HPV ctDNA results demonstrated higher sensitivity and lower cross‐reactivity between HPV types compared with HPV serology results. Furthermore, HPV ctDNA but not HPV16 E6 antibody levels were positively associated with disease burden as determined by N‐category, overall stage, and by tumor volume (ctDNA vs. volume, r = 0.48 p = 6.4e‐12; E6 vs. volume, r = −0.079 p = 0.26). Overall, this is the largest cohort to compare HPV serology and HPV ctDNA results in OPC, and these findings highlight the potential for ctDNA to augment future strategies for blood‐based early detection of HPV+ OPC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oropharyngeal NeoplasmsPapillomavirus InfectionsDNA, ViralCirculating Tumor DNAHuman Papillomavirus VirusesPapillomaviridaeHumansFemaleMaleGenotypeMiddle AgedAgedHuman papillomavirus 16Antibodies, ViralAdult

Stichwörter der Autor:innen

HPV serologycirculating tumor DNA (ctDNA)oropharyngeal cancerrisk‐stratification

Substanzen

DNA, ViralCirculating Tumor DNAAntibodies, Viral

Autor:innen und Institutionen

  • Department of Medical Biophysics, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Department of Radiation Oncology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Infections and Cancer Epidemiology Division, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Department of Otolaryngology-Head & Neck Surgery/Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Division of Medical Oncology & Haematology, Department of Medicine, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: John R de Almeida, Fei-Fei Liu, C Jillian Tsai, John N Waldron, Anna Spreafico, Enrique Sanz-Garcia, Lillian L Siu, Tim Waterboer, Geoffrey Liu, Scott V Bratman

Zitieren

APA

Penny, L., Stutheit-Zhao, E. Y., Michels, B. E., Rosing, F., Zhao, Z., Zheng, Y., Zou, J., Huang, S. H., Carlton, J., McPartlin, A., de Almeida, J. R., Goldstein, D., Hope, A., Hosni, A., Kim, J., Liu, F. F., Tsai, C. J., Waldron, J. N., Spreafico, A., …, & Bratman, S. V. (2026). HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Measurement of Disease Burden in Oropharyngeal Cancer. International Journal of Cancer. https://doi.org/10.1002/ijc.70619

Vancouver

Penny L, Stutheit-Zhao EY, Michels BE, Rosing F, Zhao Z, Zheng Y, et al. HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Measurement of Disease Burden in Oropharyngeal Cancer. International Journal of Cancer. 2026. doi:10.1002/ijc.70619

BibTeX
@article{Penny2026,
  author = {Penny, Lucas and Stutheit-Zhao, Eric Yang and Michels, Birgitta E and Rosing, Fabian and Zhao, Zhen and Zheng, Yangqiao and Zou, Jinfeng and Huang, Shao Hui and Carlton, Johnny and McPartlin, Andrew and de Almeida, John R and Goldstein, David and Hope, Andrew and Hosni, Ali and Kim, John and Liu, Fei-Fei and Tsai, C Jillian and Waldron, John N and Spreafico, Anna and Sanz-Garcia, Enrique and Siu, Lillian L and Waterboer, Tim and Liu, Geoffrey and Bratman, Scott V},
  title = {HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Measurement of Disease Burden in Oropharyngeal Cancer},
  journal = {International Journal of Cancer},
  year = {2026},
  doi = {10.1002/ijc.70619}
}
Kostenlos starten →